decoding glp 1 GLP-1 Weight Loss Medications Compound GLP-1 Poll STUNS THE

Its been very challenging

Impact of Increased Residual Gastric Content on Clinical Consequences By increasing the risk of RGC, the use of GLP-1 RAs can have negative clinical consequences on patient outcomes

2021;372:m4573

As long as a drug is in shortage, it can be made off-label via compound pharmacies

Impaired glucose tolerance and impaired fasting glucose

The prior authorization form requires your doctor to deny coverage for patients with type 2 diabetes, obstructive sleep apnea, and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) Beneficiaries with these diagnoses are eligible to receive GLP-1s through their Part D plan and therefore are ineligible to receive them through the Medicare GLP-1 Bridge, even if they otherwise meet the Medicare GLP-1 Bridge clinical criteria, according to CMSs provider site